Why and How Should We Integrate Biomarkers into Complex Trials? A Discussion on Paradigms and Clinical Research Strategies

Frauke Musial, Scott Mist, Sara Warber, Mary Jo Kreitzer, Cheryl Ritenbaugh, Christian Kessler

Research output: Contribution to journalReview article

Abstract

>bold<>italic<Background:>/italic<>/bold< Research in complementary and alternative medicine (CAM) encounters a variety of challenges, such as potentially synergistic, multimodal, and complex interventions which are often dependent on the relationship between practitioner and patient, on specific settings, and on patients' individual preferences, expectations, beliefs, and motivations. Moreover, patients seeking CAM care often suffer from chronic disease conditions, and multiple symptoms and/or pathologies. On the other hand, CAM interventions are often challenged as being solely dependent on subjective and nonspecific factors without biologically based mechanisms of action. If we agree that biomarkers as outcomes are important for the understanding of CAM interventions, a hypothesis- and strategy-driven process for the selection of the most appropriate biomarkers is needed. >bold<>italic<Methods:>/italic<>/bold< This paper presents the results of an expert panel on how to integrate biomarkers in whole system research of an interdisciplinary workshop on research methodology in CAM held in November 2012. >bold<>italic<Results:>/italic<>/bold< The following main CAM research challenges were identified: (a) finding appropriate biomarkers, which are able to picture the complex pathophysiological pathways and likewise complex interventions under study; (b) integrating these biomarkers into clinical trials in CAM; and (c) identifying the biomarkers specific to the particular CAM intervention being applied. >bold<>italic<Conclusion:>/italic<>/bold< The paper provides a disease/condition/symptom- and intervention-driven strategy regarding how to identify the outcomes of interest and possible related biomarkers. The research approach presented here allows the selected biomarkers to be grounded in conventional physiology/pathophysiology as well as complementary and alternative concepts, including traditional systems of medicine. The goal is to provide researchers in the field with a framework on how to integrate biomarkers into complex trials.

Original languageEnglish (US)
JournalComplementary Medicine Research
DOIs
StatePublished - Jan 1 2019

Fingerprint

Biomarkers
Research
Traditional Medicine
Systems Analysis
Research Personnel

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Why and How Should We Integrate Biomarkers into Complex Trials? A Discussion on Paradigms and Clinical Research Strategies. / Musial, Frauke; Mist, Scott; Warber, Sara; Kreitzer, Mary Jo; Ritenbaugh, Cheryl; Kessler, Christian.

In: Complementary Medicine Research, 01.01.2019.

Research output: Contribution to journalReview article

@article{eb1c3181ed3947029177b73052a497f7,
title = "Why and How Should We Integrate Biomarkers into Complex Trials? A Discussion on Paradigms and Clinical Research Strategies",
abstract = ">bold<>italic<Background:>/italic<>/bold< Research in complementary and alternative medicine (CAM) encounters a variety of challenges, such as potentially synergistic, multimodal, and complex interventions which are often dependent on the relationship between practitioner and patient, on specific settings, and on patients' individual preferences, expectations, beliefs, and motivations. Moreover, patients seeking CAM care often suffer from chronic disease conditions, and multiple symptoms and/or pathologies. On the other hand, CAM interventions are often challenged as being solely dependent on subjective and nonspecific factors without biologically based mechanisms of action. If we agree that biomarkers as outcomes are important for the understanding of CAM interventions, a hypothesis- and strategy-driven process for the selection of the most appropriate biomarkers is needed. >bold<>italic<Methods:>/italic<>/bold< This paper presents the results of an expert panel on how to integrate biomarkers in whole system research of an interdisciplinary workshop on research methodology in CAM held in November 2012. >bold<>italic<Results:>/italic<>/bold< The following main CAM research challenges were identified: (a) finding appropriate biomarkers, which are able to picture the complex pathophysiological pathways and likewise complex interventions under study; (b) integrating these biomarkers into clinical trials in CAM; and (c) identifying the biomarkers specific to the particular CAM intervention being applied. >bold<>italic<Conclusion:>/italic<>/bold< The paper provides a disease/condition/symptom- and intervention-driven strategy regarding how to identify the outcomes of interest and possible related biomarkers. The research approach presented here allows the selected biomarkers to be grounded in conventional physiology/pathophysiology as well as complementary and alternative concepts, including traditional systems of medicine. The goal is to provide researchers in the field with a framework on how to integrate biomarkers into complex trials.",
author = "Frauke Musial and Scott Mist and Sara Warber and Kreitzer, {Mary Jo} and Cheryl Ritenbaugh and Christian Kessler",
year = "2019",
month = "1",
day = "1",
doi = "10.1159/000498981",
language = "English (US)",
journal = "Complementary Medicine Research",
issn = "2504-2092",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Why and How Should We Integrate Biomarkers into Complex Trials? A Discussion on Paradigms and Clinical Research Strategies

AU - Musial, Frauke

AU - Mist, Scott

AU - Warber, Sara

AU - Kreitzer, Mary Jo

AU - Ritenbaugh, Cheryl

AU - Kessler, Christian

PY - 2019/1/1

Y1 - 2019/1/1

N2 - >bold<>italic<Background:>/italic<>/bold< Research in complementary and alternative medicine (CAM) encounters a variety of challenges, such as potentially synergistic, multimodal, and complex interventions which are often dependent on the relationship between practitioner and patient, on specific settings, and on patients' individual preferences, expectations, beliefs, and motivations. Moreover, patients seeking CAM care often suffer from chronic disease conditions, and multiple symptoms and/or pathologies. On the other hand, CAM interventions are often challenged as being solely dependent on subjective and nonspecific factors without biologically based mechanisms of action. If we agree that biomarkers as outcomes are important for the understanding of CAM interventions, a hypothesis- and strategy-driven process for the selection of the most appropriate biomarkers is needed. >bold<>italic<Methods:>/italic<>/bold< This paper presents the results of an expert panel on how to integrate biomarkers in whole system research of an interdisciplinary workshop on research methodology in CAM held in November 2012. >bold<>italic<Results:>/italic<>/bold< The following main CAM research challenges were identified: (a) finding appropriate biomarkers, which are able to picture the complex pathophysiological pathways and likewise complex interventions under study; (b) integrating these biomarkers into clinical trials in CAM; and (c) identifying the biomarkers specific to the particular CAM intervention being applied. >bold<>italic<Conclusion:>/italic<>/bold< The paper provides a disease/condition/symptom- and intervention-driven strategy regarding how to identify the outcomes of interest and possible related biomarkers. The research approach presented here allows the selected biomarkers to be grounded in conventional physiology/pathophysiology as well as complementary and alternative concepts, including traditional systems of medicine. The goal is to provide researchers in the field with a framework on how to integrate biomarkers into complex trials.

AB - >bold<>italic<Background:>/italic<>/bold< Research in complementary and alternative medicine (CAM) encounters a variety of challenges, such as potentially synergistic, multimodal, and complex interventions which are often dependent on the relationship between practitioner and patient, on specific settings, and on patients' individual preferences, expectations, beliefs, and motivations. Moreover, patients seeking CAM care often suffer from chronic disease conditions, and multiple symptoms and/or pathologies. On the other hand, CAM interventions are often challenged as being solely dependent on subjective and nonspecific factors without biologically based mechanisms of action. If we agree that biomarkers as outcomes are important for the understanding of CAM interventions, a hypothesis- and strategy-driven process for the selection of the most appropriate biomarkers is needed. >bold<>italic<Methods:>/italic<>/bold< This paper presents the results of an expert panel on how to integrate biomarkers in whole system research of an interdisciplinary workshop on research methodology in CAM held in November 2012. >bold<>italic<Results:>/italic<>/bold< The following main CAM research challenges were identified: (a) finding appropriate biomarkers, which are able to picture the complex pathophysiological pathways and likewise complex interventions under study; (b) integrating these biomarkers into clinical trials in CAM; and (c) identifying the biomarkers specific to the particular CAM intervention being applied. >bold<>italic<Conclusion:>/italic<>/bold< The paper provides a disease/condition/symptom- and intervention-driven strategy regarding how to identify the outcomes of interest and possible related biomarkers. The research approach presented here allows the selected biomarkers to be grounded in conventional physiology/pathophysiology as well as complementary and alternative concepts, including traditional systems of medicine. The goal is to provide researchers in the field with a framework on how to integrate biomarkers into complex trials.

UR - http://www.scopus.com/inward/record.url?scp=85064352321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064352321&partnerID=8YFLogxK

U2 - 10.1159/000498981

DO - 10.1159/000498981

M3 - Review article

AN - SCOPUS:85064352321

JO - Complementary Medicine Research

JF - Complementary Medicine Research

SN - 2504-2092

ER -